Home » General » Tampax Class Action Lawsuit: Lead, PFAS Claims and Status (November 2026)

Tampax Class Action Lawsuit: Lead, PFAS Claims and Status (November 2026)

The Tampax class action lawsuit story is really several cases against Procter & Gamble (P&G), the maker of Tampax tampons. One group of cases claims P&G’s labels hide the alleged presence of lead and other metals. Another case claimed Tampax Pure Cotton tampons contain PFAS, the so-called forever chemicals. As of November 2026, the PFAS case has been dismissed and is on appeal. The lead case in California, Barton v. Procter & Gamble, was certified as a class action on September 29, 2026. No settlement or claim form exists. P&G denies the claims, and none of the allegations has been proven. This guide covers the courts, case numbers, rulings and the FDA’s response. It is general information, not legal advice.

Quick Facts

ItemDetails
DefendantThe Procter & Gamble Company
Lead case (California)Barton v. The Procter & Gamble Co., No. 3:24-cv-01332-GPC-SBC (S.D. Cal.)
Products in lead caseTampax Pearl and Tampax Radiant
Lead case statusClass certified September 29, 2026; P&G asked the Ninth Circuit to review
PFAS caseBounthon v. The Procter & Gamble Co., No. 23-cv-00765-AMO (N.D. Cal.)
PFAS case statusDismissed July 7, 2025; plaintiffs’ appeal pending
SettlementNone as of November 2026
FDA positionJuly 2026 study found low toxicological concern from metals in tampons

The PFAS Case Over Tampax Pure Cotton

The PFAS case claimed that Tampax Pure Cotton tampons, sold with a “100% organic cotton core” label, contain PFAS. A federal judge dismissed it in 2025 after finding the testing claims too weak.

Three California women filed Bounthon v. Procter & Gamble on February 21, 2023, in the U.S. District Court for the Northern District of California. Judge Araceli Martínez-Olguín handled the case. The plaintiffs relied on total organic fluorine (TOF) testing. On October 15, 2024, the judge ruled that TOF testing alone did not plausibly show PFAS, because it can pick up fluorine compounds that are not PFAS. She allowed one more amendment.

On July 7, 2025, the court dismissed the third amended complaint without leave to amend again. The plaintiffs appealed to the Ninth Circuit (No. 25-4978). A business advocacy group filed a brief supporting P&G on March 23, 2026. We found no Ninth Circuit ruling as of November 2026.

Some searches mention a “Dalton v. P&G” PFAS case in New York. We found no such case in the court records and reports we checked. The Tampax Pure Cotton PFAS case is Bounthon, filed in California.

The 2024 Study on Metals in Tampons

A July 2024 study led by researchers at the University of California, Berkeley, found measurable levels of metals, including lead and arsenic, in every tampon it tested. That study sparked the lead lawsuits.

The study, “Tampons as a source of exposure to metal(loid)s,” appeared in Environment International (volume 190). Researchers tested 30 tampons from 14 brands and looked for 16 metals and metalloids. Lead was higher in non-organic tampons, and arsenic was higher in organic ones. The study did not measure how much metal, if any, enters the body during use.

The Lead Cases Against P&G

Several proposed class actions claim P&G sold Tampax tampons with labels that suggest safety while the products allegedly contain lead. The California case has moved the furthest.

CaseCourt and NumberFiledStatus as of November 2026
Barton v. Procter & GambleS.D. Cal., No. 3:24-cv-01332July 29, 2024Class certified September 29, 2026
Sanchez v. Procter & GambleS.D. Ohio, No. 1:25-cv-00852November 19, 2025Early stage; no ruling found
Otkina v. Procter & GambleN.D. Ill., No. 1:26-cv-00773January 2026Early stage; seeks a class outside California
Bounthon v. Procter & Gamble (PFAS)N.D. Cal., No. 23-cv-00765February 21, 2023Dismissed; on appeal

In Barton, the plaintiffs say their own lab tests found about 0.181 micrograms of lead per gram in Tampax Pearl and 0.123 in Tampax Radiant. They challenge label claims such as “#1 U.S. Gynecologist Recommended Tampon Brand,” “Free of Perfume” and “Clinically Tested Gentle to Skin.” A parallel suit by the same lead plaintiff targets Kimberly-Clark’s U by Kotex tampons in the same court.

Key Rulings in the Barton Case

Judge Gonzalo P. Curiel has let the core consumer claims move forward and has now certified a California class. P&G has won some smaller points along the way.

  • February 13, 2025: The court refused to pause the case for the FDA and rejected P&G’s Proposition 65 argument. It dismissed the omission claims with leave to amend, saying the testing details were too thin.
  • August 2025: The court largely denied P&G’s next motion to dismiss. It wrote that what counts as an “unsafe level” of lead is a question of fact. It dismissed the “unfair” prong of the state unfair competition claim with prejudice.
  • November 2025: P&G asked to move the case to Ohio federal court. The plaintiffs opposed, and the case stayed in San Diego.
  • September 29, 2026: The court certified a class of California buyers of any Tampax Pearl or Radiant tampons from July 29, 2020, until notice goes out. Personal injury claims are excluded.
  • October 13, 2026: P&G filed a petition asking the Ninth Circuit for permission to appeal the certification order (No. 26-6769).

Class certification is a procedural step. It does not mean the court found the tampons unsafe or that P&G broke the law. You can follow filings through the U.S. District Court for the Southern District of California. To learn what certification means, see our explainer on how class actions work.

What P&G and the FDA Say

P&G denies the claims and has argued that tampon safety is a question for the FDA, not the courts. The FDA’s own testing found little reason for concern.

In 2024, P&G argued that an FDA review of metals in tampons made the California case unnecessary. The court disagreed. In 2024, the FDA also ordered an independent review of published research. Its literature review is posted on the agency’s website.

In July 2026, FDA scientists published lab results in Toxicological Sciences. They tested 11 tampon products from six brands and detected 19 metals, including trace arsenic, cadmium and lead. Under deliberately extreme conditions, only a small share of those metals was released. The margins of safety were 7 or greater, which the agency read as a low toxicological concern.

Toxic Shock Syndrome Warnings

None of the current Tampax class actions is about toxic shock syndrome (TSS). TSS warnings are a separate, long-standing FDA labeling rule.

FDA rules at 21 CFR 801.430 require tampon packages to warn about TSS, a rare but serious illness linked to tampon use. Packages must also use standard absorbency terms, such as “light” or “super.” The FDA advises using the lowest absorbency needed. Anyone with a TSS-related injury should speak with a doctor and a licensed attorney, because those claims are personal injury claims, not part of the Barton class.

Conclusion

As of November 2026, there is no Tampax settlement and no claim form. The PFAS case, Bounthon, was dismissed in July 2025 and is on appeal. The lead case, Barton, won class certification for California buyers on September 29, 2026, and P&G is seeking Ninth Circuit review. Similar suits are pending in Ohio and Illinois. The FDA’s 2026 study found low health concern from metals in tampons, and P&G denies all claims. Keep your receipts and watch the court dockets. For another large consumer case still working through the courts, read our Ticketmaster case update, or browse our latest class action coverage.

Frequently Asked Questions

Is there a Tampax settlement I can claim from?

No. As of November 2026, no settlement has been reached in any Tampax case, and no claim form exists.

Who is in the certified Tampax class?

California citizens who bought Tampax Pearl or Tampax Radiant tampons in California from July 29, 2020, until class notice is sent. People claiming personal injury are excluded.

What happened to the Tampax PFAS lawsuit?

The court dismissed Bounthon v. Procter & Gamble on July 7, 2025. The plaintiffs appealed to the Ninth Circuit, and no ruling had been found as of November 2026.

Did the FDA find tampons unsafe?

No. FDA testing published in July 2026 found trace metals but a low toxicological concern for users.

Has P&G admitted wrongdoing?

No. P&G denies the claims, and no court has found that Tampax products contain harmful levels of lead or PFAS.

Do I need to do anything now?

Not yet. If the class moves forward, notice will explain your rights. A licensed attorney can review a possible injury claim.

Sources

Barton v. The Procter & Gamble Co., No. 3:24-cv-01332-GPC-SBC (S.D. Cal.), Order on Motion to Dismiss, February 13, 2025
Barton v. Procter & Gamble Co., 766 F. Supp. 3d 1045 (S.D. Cal. 2025)
Barton v. The Procter & Gamble Co., Ninth Circuit No. 26-6769, docket (petition filed October 13, 2026)
Bounthon v. The Procter & Gamble Co., No. 23-cv-00765-AMO (N.D. Cal.), Order of October 15, 2024, and dismissal of July 7, 2025
Washington Legal Foundation amicus brief, Bounthon v. Procter & Gamble, Ninth Circuit, March 23, 2026
Shearston et al., “Tampons as a source of exposure to metal(loid)s,” Environment International, vol. 190, 2024
NIEHS Environmental Factor, “Metals in tampons,” August 2024
FDA study in Toxicological Sciences, June 2026, as reported by RAPS (July 9, 2026) and ConsumerAffairs (July 17, 2026)
21 CFR 801.430, user labeling for menstrual tampons
Law360 and Mealey’s case reports, 2024 to 2026